Paul Tudor Jones Homology Medicines, Inc. Transaction History

Tudor Investment Corp Et Al

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.55 - $3.01 $939 - $1,824	-606 Reduced 0.52%	115,623 $186,000
Q2 2022 Aug 15, 2022	SELL	$1.39 - $3.12 $36,159 - $81,163	-26,014 Reduced 18.29%	116,229 $229,000
Q1 2022 May 16, 2022	BUY	$2.6 - $4.17 $235,307 - $377,397	90,503 Added 174.92%	142,243 $432,000
Q4 2021 Feb 14, 2022	BUY	$3.64 - $7.78 $188,333 - $402,537	51,740 New	51,740 $188,000
Q3 2021 Nov 15, 2021	SELL	$6.01 - $8.71 $776,564 - $1.13 Million	-129,212 Closed	0 $0

Q2 2021 Aug 16, 2021	BUY	$6.02 - $9.64 $777,856 - $1.25 Million	129,212 New	129,212 $939,000
Q1 2021 May 17, 2021	SELL	$9.17 - $14.8 $534,867 - $863,254	-58,328 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$8.92 - $13.29 $520,285 - $775,179	58,328 New	58,328 $659,000
Q3 2019 Nov 14, 2019	SELL	$14.74 - $22.28 $149,743 - $226,342	-10,159 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$18.35 - $30.34 $186,417 - $308,224	10,159 New	10,159 $199,000

100K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.